MeVis Medical Financials
| M3V Stock | 24.80 0.20 0.80% |
MeVis |
Please note, the imprecision that can be found in MeVis Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of MeVis Medical Solutions. Check MeVis Medical's Beneish M Score to see the likelihood of MeVis Medical's management manipulating its earnings.
| Instrument | Germany Stock View All |
| Exchange | Stuttgart Exchange |
| ISIN | DE000A0LBFE4 |
| Benchmark | Dow Jones Industrial |
MeVis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MeVis Medical's current stock value. Our valuation model uses many indicators to compare MeVis Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MeVis Medical competition to find correlations between indicators driving MeVis Medical's intrinsic value. More Info.MeVis Medical Solutions is regarded fifth in current valuation category among its peers. It is regarded second in price to book category among its peers . The ratio of Current Valuation to Price To Book for MeVis Medical Solutions is about 16,888,148 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MeVis Medical's earnings, one of the primary drivers of an investment's value.MeVis Medical Solutions Systematic Risk
MeVis Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MeVis Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on MeVis Medical Solutions correlated with the market. If Beta is less than 0 MeVis Medical generally moves in the opposite direction as compared to the market. If MeVis Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MeVis Medical Solutions is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MeVis Medical is generally in the same direction as the market. If Beta > 1 MeVis Medical moves generally in the same direction as, but more than the movement of the benchmark.
MeVis Medical Thematic Clasifications
MeVis Medical Solutions is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
MeVis Medical February 1, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of MeVis Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MeVis Medical Solutions. We use our internally-developed statistical techniques to arrive at the intrinsic value of MeVis Medical Solutions based on widely used predictive technical indicators. In general, we focus on analyzing MeVis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MeVis Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.46 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 4.96 | |||
| Value At Risk | (1.64) | |||
| Potential Upside | 1.69 |
Additional Tools for MeVis Stock Analysis
When running MeVis Medical's price analysis, check to measure MeVis Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MeVis Medical is operating at the current time. Most of MeVis Medical's value examination focuses on studying past and present price action to predict the probability of MeVis Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MeVis Medical's price. Additionally, you may evaluate how the addition of MeVis Medical to your portfolios can decrease your overall portfolio volatility.